Cover Image

Clinical profile and management of acute invasive fungal rhinosinusitis - our experience with 21 patients

AMIT KUMAR TYAGI .

Abstract


Objective- Acute invasive fungal rhinosinusitis (AIFR) is a rapidly progressive disease, which usually                develops in patients with uncontrolled diabetes mellitus (DM) and immunocompromised patients. The purpose of this study was to look retrospectively at the clinical profile, management and outcome of these patients. Study design- Retrospective chart review Settings- Tertiary care hospital Materials and methods- A retrospective chart review was done of patients diagnosed with AIFR between the years 2006 to 2011.         RESULTS- Among the 21 patients, 17 (80.9) had uncontrolled diabetes mellitus. Nasal obstruction was the predominant symptom (16 patients, 76.2 percent). Mucosal changes were most commonly observed in the middle meatus (18 patients, 85.7 percent) and rhino-orbital disease was the most common presentation (11 patients, 52.4 percent). The most common causative fungal agent was Rhizopus (16 patients, 76.2            percent). Multiple surgeries were required in all except those patients who underwent endoscopic debridement with orbital exenteration. The mortality rate was 14.3 percent (3 patients). Conclusions- Early and aggressive surgical debridement, intravenous amphotericin B and prompt treatment of the  underlying disease are the mainstay of AIFR treatment.                   Orbital involvement leads to higher mortality. Early orbital exenteration in patients, when indicated, has a better                outcome because of reduced intracranial spread. Long term follow up and multiple surgical debridements when required, particularly in those who have not had orbital exenteration, are essential for a good outcome.


Full Text:

PDF

References


Berlinger NT. Sinusitis in immunodeficient and immunosuppressed patients. The Laryngoscope. 1985 Jan 1;95(1):29–33.

Waitzman AA, Birt BD. Fungal sinusitis. J Otolaryngol. 1994 Aug;23(4):244–9.

deShazo RD, O’Brien M, Chapin K, Soto-Aguilar M, Gardner L, Swain R. A new classification and diagnostic criteria for invasive fungal sinusitis. Arch. Otolaryngol. Head Neck Surg. 1997 Nov;123(11):1181–8.

Ferguson BJ. Definitions of fungal rhinosinusitis. Otolaryngologic Clinics Of North America. 2000;33(2):227–35.

Alobid I, Bernal M, Calvo C, Vilaseca I, Berenguer J, Alós L. Treatment of rhinocerebral mucormycosis by combination of endoscopic sinus debridement and amphotericin B. Am J Rhinol. 2001 Oct;15(5):327–31.

Brandwein M. Histopathology of sinonasal fungal disease. Otolaryngol. Clin. North Am. 1993 Dec;26(6):949–81.

Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto). Br. J. Haematol. 1997 Nov;99(2):331–6.

Peterson KL, Wang M, Canalis RF, Abemayor E. Rhinocerebral Mucormycosis: Evolution of the Disease and Treatment Options. The Laryngoscope. 1997 Jul 1;107(7):855–62.

Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses. 2001 Oct 1;44(7 8):253–60.

Süslü AE, Öretmenolu O, Süslü N, Yücel ÖT, Önerci TM. Acute invasive fungal rhinosinusitis: our experience with 19 patients. European Archives of Oto-Rhino-Laryngology. 2008 May 10;266(1):77–82.

Parikh SL, Venkatraman G, Delgaudio JM. Invasive Fungal Sinusitis: A 15-Year Review from a Single Institution. American Journal of Rhinology. 2004;18(2):75–81.

Kennedy CA, Adams GL, Neglia JP, Giebink GS. Impact of surgical treatment on paranasal

fungal infections in bone marrow transplant patients. Otolaryngol Head Neck Surg. 1997 Jun;116(6 Pt 1):610–6.

Gillespie MB, O’Malley BW, Francis HW. An Approach to Fulminant Invasive Fungal Rhinosinusitis in the Immunocompromised Host. Arch Otolaryngol Head Neck Surg. 1998 May 1;124(5):520–6.

Han DH, An S-Y, Kim SW, Kim D-Y, Rhee C-S, Lee CH, et al. Primary and secondary fungal infections of the paranasal sinuses: clinical features and treatment outcomes. Acta Otolaryngol Suppl. 2007 Oct;(558):78–82.

Park AH, Muntz HR, Smith ME, Afify Z, Pysher T, Pavia A. Pediatric Invasive Fungal Rhinosinusitis in Immunocompromised Children With Cancer. Otolaryngology -- Head and Neck Surgery. 2005;133(3):411 –416.

DelGaudio JM, Swain RE, Kingdom TT, Muller S, Hudgins PA. Computed Tomographic Findings in Patients With Invasive Fungal Sinusitis. Arch Otolaryngol Head Neck Surg. 2003 Feb 1;129(2):236–40.

Silverman CS, Mancuso AA. Periantral soft-tissue infiltration and its relevance to the early detection of Invasive fungal sinusitis: CT and MR findings. AJNR Am J Neuroradiol. 1998 Feb;19(2):321–5.

Som PM, Curtin HD. Chronic inflammatory sinonasal diseases including fungal infections. The role of imaging. Radiol. Clin. North Am. 1993 Jan;31(1):33–44.

Aribandi M, McCoy VA, Bazan C 3rd. Imaging features of invasive and noninvasive fungal sinusitis: a review. Radiographics. 2007 Oct;27(5):1283–96.

Howells RC, Ramadan HH. Usefulness of computed tomography and magnetic resonance in fulminant invasive fungal rhinosinusitis. Am J Rhinol. 2001 Aug;15(4):255 –61.

Gillespie MB, O’Malley BW. An algorithmic approach to the diagnosis and management of invasive fungal rhinosinusitis in the immunocompromised patient. Otolaryngol. Clin. North Am. 2000 Apr;33(2):323–34.

Gillespie MB, Huchton DM, O’Malley BW. Role of middle turbinate biopsy in the diagnosis of fulminant invasive fungal rhinosinusitis. Laryngoscope. 2000 Nov;110(11):1832–6.

Hofman V, Castillo L, Bétis F, Guevara N, Gari-Toussaint M, Hofman P. Usefulness of frozen section in rhinocerebral mucormycosis diagnosis and management. Pathology. 2003 Jun;35(3):212–6.

Pelton RW, Peterson EA, Patel BC, Davis K. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities. Ophthal Plast Reconstr Surg. 2001 Jan;17(1):62–6.

Kasapoglu F, Coskun H, Ozmen OA, Akalin H, Ener B. Acute invasive fungal rhinosinusitis: evaluation of 26 patients treated with endonasal or open surgical procedures. Otolaryngol Head Neck Surg. 2010 Nov;143(5):614–20.

Paulgoering P, Berlinger NT, Weisdorf DJ. Aggressive combined modality treatment of progressive sinonasal fungal infections in immunocompromised patients. The American Journal of Medicine. 1988 Nov;85(5):619–23.

Goldstein EJC, Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J, Ibrahim AS. Recent Advances in the Management of Mucormycosis: From Bench to Bedside. Clinical Infectious Diseases. 2009 Jun 15;48(12):1743 –1751.

Choudhury D, Ahmed Z. Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol. 2006 Feb;2(2):80–91.

Eliashar R, Resnick IB, Goldfarb A, Wohlgelernter J, Gross M. Endoscopic surgery for sinonasal invasive aspergillosis in bone marrow transplantation patients. Laryngoscope. 2007 Jan;117(1):78–81.

Jiang RS, Hsu CY. Endoscopic sinus surgery for rhinocerebral mucormycosis. Am J Rhinol. 1999 Apr;13(2):105–9.

Iwen PC, Rupp ME, Hinrichs SH. Invasive Mold Sinusitis: 17 Cases in Immunocompromised Patients and Review of the Literature. Clinical Infectious Diseases. 1997 Jun;24(6):1178–84.

Trigg ME, Morgan D, Burns TL, Kook H, Rumelhart SL, Holida MD, et al. Successful program to prevent aspergillus infections in children undergoing marrow transplantation: use of nasal amphotericin. Bone Marrow Transplant. 1997 Jan;19(1):43–7.

Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D’Souza O. Rhino-orbitocerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol. 2003 Sep;51(3):231–6.

Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases. Clinical Infectious Diseases. 2005 Sep 1;41(5):634–53.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University